1. The psychosocial impact of a chronic disease in Ireland: Burdens and helpful practices for a life with epidermolysis bullosa.
- Author
-
Salamon, Gudrun, Field‐Werners, Ursula, Strobl, Sophie, Hübl, Vinzenz, and Diem, Anja
- Subjects
CHRONIC diseases & psychology ,COMMUNITY health services ,MEDICAL care use ,SOMATOFORM disorders ,HEALTH services accessibility ,PSYCHOTHERAPY ,RESEARCH funding ,HEALTH status indicators ,ENDOWMENTS ,SATISFACTION ,EPIDERMOLYSIS bullosa ,RARE diseases ,DISEASE management ,QUESTIONNAIRES ,KRUSKAL-Wallis Test ,BANDAGES & bandaging ,MANN Whitney U Test ,DESCRIPTIVE statistics ,SEVERITY of illness index ,THEMATIC analysis ,FAMILY attitudes ,PHYSICIAN practice patterns ,RESEARCH methodology ,QUALITY of life ,PATIENT-professional relations ,EXTENDED families ,FACTOR analysis ,QUALITY assurance ,COMPARATIVE studies ,DATA analysis software ,SOCIAL support ,INTERPERSONAL relations ,SURGICAL dressings ,DRUGS ,PSYCHOSOCIAL factors ,PHYSICAL mobility ,MEDICAL care costs ,NONPARAMETRIC statistics ,PATIENTS' attitudes - Abstract
Objective: Although Ireland has one of the highest levels of well‐being in Europe, having a health condition has been found to have a direct negative impact. The aim of this study is to evaluate the current situation and the experiences of patients with epidermolysis bullosa (EB), a rare genetic skin disease, and their relatives living in Ireland, with a focus on burdens and helpful practices. Methods and Measures: In a mixed‐methods design, a series of standardised questionnaires were combined with open‐ended questions. Via an online survey, data from n = 59 EB patients and relatives of EB patients living in Ireland were collected. Results: EB affects both the patients and their relatives. Burdens were found in relation to the visibility of EB, the degree of severity, the current health status, reduced mobility, the financial impact of EB, the psychosocial impact and personal and social resources. The paper also analyses existing resources and highlights opportunities for support and needs of improvement. Conclusion: Quality of life with EB is influenced by somatic symptoms and the psychosocial burden. Individual helpful practices in dealing with this rare disease can be considered as mediators, but they need to be supported by structural and healthcare improvements. Patient or Public Contribution: The perspective of EB patients, their relatives and EB experts were taken into account in the development of the study design via two feedback loops with the EB patient organisations DEBRA Ireland and DEBRA Austria. The design was adapted accordingly. Additionally, by including open‐ended questions, patients and relatives could contribute their individual perspectives and add insights into their lives with EB that might not have been captured with the structured online survey alone. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF